Topiramate: Clinical Uses and Pharmacological Properties

Pharmacology and Mechanism of Action

The exact mechanism for weight loss effects of topiramate is not fully understood, but it appears to decrease caloric intake and may reduce appetite, as reported in Gastroenterology 1

The American College of Cardiology is not relevant here, however, topiramate is FDA-approved for migraine prophylaxis, with a target dosing of typically 100 mg/day, as noted in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2

The National Institute of Health is not relevant here, however, topiramate, in combination with phentermine, is used for chronic weight management in adults with BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities, as reported in Gastroenterology 1, 3

The initial dose of topiramate for various indications is 25-50 mg daily with increases of 25-50 mg every 3-7 days as tolerated, as recommended in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 4
When used for weight loss in combination with phentermine, the starting dose is 3.75 mg/23 mg with titration to maintenance doses, as reported in Gastroenterology 1, 3

Metabolic acidosis due to carbonic anhydrase inhibition is a serious adverse effect of topiramate, as reported in Gastroenterology 3
Topiramate increases the risk of kidney stones, and patients should maintain adequate hydration, as noted in Gastroenterology 3
Teratogenic effects, including an increased risk of orofacial clefts, have been associated with topiramate use during pregnancy, as reported in Gastroenterology and Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2, 3

Topiramate may be used for the treatment of PTSD-associated nightmares, as reported in the Journal of Clinical Sleep Medicine 5
Topiramate may be used for the management of some eating disorders, as reported in Gastroenterology 3

Topiramate should be discontinued gradually to minimize the risk of increased seizure activity, as recommended in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2
Women of reproductive potential should be informed that topiramate can reduce the efficacy of hormonal contraceptives, as noted in Praxis Medical Insights: Practical Summaries of Clinical Guidelines 2, 4